Stock To Watch: Globus Medical, Inc. (NYSE:GMED)


The leading market experts have placed a mean price target of $28.40 on Globus Medical, Inc. (NYSE:GMED) stock. This price level, which is estimated to be attained in one-year indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $0.30 a share for the upcoming quarter and $1.20 for the current fiscal. Technical View The technical analysis of Globus Medical, Inc. Class A Co plainly substantiates that the 50-day moving average of Globus Medical, Inc. Class A Co is $24.03, and stock is hovering 0.46 or +1.91% distant from $24.03. It is noted that the 200-day MA is $24.50, and Globus Medical, Inc. Class A Co stock is $-0.01 or -0.05% off from this point. Globus Medical, Inc. (NYSE:GMED) 52-week high is $28.99 and the 52-week low is $20.48. This explains if the stock moves $-4.50, it will post a 52-week high. In event of $+19.58% points decline, a 52-week low will be hit. Taking the Valuation Aspect To emphasize the valuation of Globus Medical, Inc. Class A Co, shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Globus Medical, Inc. (NYSE:GMED) ratio came in at 20.41. The stock last ended the trading session at $24.49 and registered a market cap of $2.34B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Globus Medical, Inc. (NYSE:GMED) PEG ratio is at 1.65.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 5 times, 1 visits today)